Xanadu Q3 Loss Widens to $32.2M as R&D Spending Jumps 67%
XNDU is trading near its 52-week low of $2.34 (11% above the low).
Summary
Xanadu's Q3 net loss widened to $32.2 million as R&D expense jumped 67% year over year on higher engineering headcount and material costs. Revenue rose 32% to $1.30 million, driven by DARPA QBI revenue and partnership engagements, partly offset by the completion of prior-year contracts. The company also locked in $140 million in Canadian government funding plus a $10 million DARPA extension to fund R&D. This follows the wider Q2 loss of $42.1 million reported in August, with material weaknesses in internal controls still unresolved. The cash burn is the story: a sub-$1 billion market cap company spending heavily on photonics while revenue remains in the low single-digit millions. Management targets a year-end 2026 system loss of 10.2 and up to 200 logical qubits by 2029, 500 by 2030 and 1,000 by 2031.
At the time of this announcement, XNDU was trading at $2.59 on NASDAQ in the Technology sector, with a market capitalization of approximately $852.3M. The 52-week trading range was $2.34 to $42.44. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.